Brief: Radiopharm Theranostics Signs Agreement With Northstar Medical Radioisotopes For The Supply Of Non-Carrier Added Actinium-225
26/10/2022 13:13
Oct 26 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* RADIOPHARM THERANOSTICS SIGNS AGREEMENT WITH NORTHSTAR
MEDICAL
RADIOISOTOPES FOR THE SUPPLY OF NON-CARRIER ADDED (N.C.A.)
ACTINIUM-225
Source text for Eikon: ID:nBw3NfCF8a
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%